Literature DB >> 19748222

Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England.

Philip P Goodney1, Brian W Nolan, Andres Schanzer, Jens Eldrup-Jorgensen, Daniel J Bertges, Andrew C Stanley, David H Stone, Daniel B Walsh, Richard J Powell, Donald S Likosky, Jack L Cronenwett.   

Abstract

BACKGROUND: Optimal patient selection for lower extremity bypass surgery requires surgeons to predict which patients will have durable functional outcomes following revascularization. Therefore, we examined risk factors that predict amputation or graft occlusion within the first year following lower extremity bypass.
METHODS: Using our regional quality-improvement initiative in 11 hospitals in northern New England, we studied 2,306 lower extremity bypass procedures performed in 2,031 patients between January 2003 and December 2007. Sixty surgeons contributed to our database, and over 100 demographic and clinical variables were abstracted by trained researchers. Cox proportional hazards models were used to generate hazard ratios and surrounding 95% confidence intervals (CIs) for our combined outcome measure of major amputation (above-knee or below-knee) or permanent graft occlusion (loss of secondary patency) occurring within the first year postoperatively.
RESULTS: We found that within our cohort of 2,306 bypass procedures 17% resulted in an amputation or graft occlusion within 1 year of surgery. Of the 143 amputations performed (8% of all limbs undergoing bypasses), 17% occurred in the setting of a patent graft. Similarly, of the 277 graft occlusions (12% of all bypasses), 42% resulted in a major amputation. We identified eight preoperative patient characteristics associated with amputation or graft occlusion in multivariate analysis: age <50, nonambulatory status preoperatively, dialysis dependence, diabetes, critical limb ischemia, need for venovenostomy, tarsal target, and living preoperatively in a nursing home. While patients with no risk factors had 1-year amputation/occlusion rates that were <1%, patients with three or more risk factors had a nearly 30% chance of suffering amputation or graft occlusion by 1 year postoperatively. When we compared risk-adjusted rates of amputation/occlusion across centers, we found that one center in our region performed significantly better than expected (observed/expected ratio 0.7, 95% CI 0.6-0.9, p < 0.04).
CONCLUSION: Preoperative risk factors allow surgeons to predict the risk of amputation or graft occlusion following lower extremity bypass and to more precisely inform patients about their operative risk and functional outcomes. Additionally, our model facilitates comparison of risk-adjusted outcomes across our region. We believe quality-improvement measures such as these will allow surgeons to identify best practices and thereby improve outcomes across centers. Copyright 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19748222     DOI: 10.1016/j.avsg.2009.06.015

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  18 in total

1.  Variation in the use of lower extremity vascular procedures for critical limb ischemia.

Authors:  Philip P Goodney; Lori L Travis; Brahmajee K Nallamothu; Kerianne Holman; Bjoern Suckow; Peter K Henke; F Lee Lucas; David C Goodman; John D Birkmeyer; Elliott S Fisher
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.

Authors:  Catherine K Chang; Salvatore T Scali; Robert J Feezor; Adam W Beck; Alyson L Waterman; Thomas S Huber; Scott A Berceli
Journal:  J Vasc Surg       Date:  2014-07-16       Impact factor: 4.268

3.  Relationship between regional spending on vascular care and amputation rate.

Authors:  Philip P Goodney; Lori L Travis; Benjamin S Brooke; Randall R DeMartino; David C Goodman; Elliott S Fisher; John D Birkmeyer
Journal:  JAMA Surg       Date:  2014-01       Impact factor: 14.766

4.  Clinical factors that influence the cellular responses of saphenous veins used for arterial bypass.

Authors:  Michael Sobel; Shinsuke Kikuchi; Lihua Chen; Gale L Tang; Tom N Wight; Richard D Kenagy
Journal:  J Vasc Surg       Date:  2018-06-15       Impact factor: 4.268

5.  Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb.

Authors:  Donald T Baril; Philip P Goodney; William P Robinson; Brian W Nolan; David H Stone; YouFu Li; Jack L Cronenwett; Andres Schanzer
Journal:  J Vasc Surg       Date:  2012-04-04       Impact factor: 4.268

6.  Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice.

Authors:  Philip P Goodney; Andres Schanzer; Randall R Demartino; Brian W Nolan; Nathanael D Hevelone; Michael S Conte; Richard J Powell; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2011-02-18       Impact factor: 4.268

7.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

8.  Outcomes of lower extremity revascularization among the hemodialysis-dependent.

Authors:  John M Fallon; Philip P Goodney; David H Stone; Virendra I Patel; Brian W Nolan; Jeffrey A Kalish; Yuanyuan Zhao; Allen D Hamdan
Journal:  J Vasc Surg       Date:  2015-08-05       Impact factor: 4.268

9.  Regional intensity of vascular care and lower extremity amputation rates.

Authors:  Philip P Goodney; Kerianne Holman; Peter K Henke; Lori L Travis; Justin B Dimick; Therese A Stukel; Elliott S Fisher; John D Birkmeyer
Journal:  J Vasc Surg       Date:  2013-02-01       Impact factor: 4.268

10.  Endovascular therapy is effective treatment for focal stenoses in failing infrapopliteal vein grafts.

Authors:  Gregory G Westin; Ehrin J Armstrong; Usman Javed; Christopher R Balwanz; Haseeb Saeed; William C Pevec; John R Laird; David L Dawson
Journal:  Ann Vasc Surg       Date:  2014-08-06       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.